Not Yet RecruitingPhase 4ACTRN12605000745640

Does metoclopramide improve quality of endoscopy in acute upper gastrointestinal bleeding?.


Sponsor

Pharmacy department , Southerm Health.

Enrollment

70 participants

Start Date

May 15, 2006

Study Type

Interventional

Conditions


Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Does metoclopramide improve quality of endoscopy in acute upper gastrointestinal bleeding?. It is looking for adults aged 18 and older who may be eligible to participate. Participants may need to meet certain health requirements, including: upper GI bleeding defined as either fresh and bright red or coffee ground haematemesis, Admission within 12 hours of initial clinical signs of bleeding and Written informed consent from patient. Some medical conditions may prevent you from joining this study.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

This study aims to investigate whether the administration of intravenous 10mg metoclopramide, 30-60minutes prior to endoscopy will improve the quality of endoscopic examination, will reduce the durati

This study aims to investigate whether the administration of intravenous 10mg metoclopramide, 30-60minutes prior to endoscopy will improve the quality of endoscopic examination, will reduce the duration of endoscopic procedure and will decrease the need for repeat endoscopy


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12605000745640


Related Trials